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Overview of Atrial Fibrillation
• Atrial fibrillation (Afib) causes the upper chambers of the heart to 
beat irregularly (quiver), potentially leading to clotting in atria 
which could lodge in artery leading to the brain which can result in 
stroke
• Most common dysrhythmia in the US
• Risk factors
• Increased age
• High blood pressure
• Heart disease
• Increased alcohol use
• Family history
• Sleep apnea
• Elite athletes
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2010 Atrial Arrhythmia Summit 
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• 17 / 317 (5.4%) astronauts 
diagnosed with atrial fibrillation
• Age of presentation was lower in 
astronauts than in the general 
population (~40 vs. ~60 yrs old)
• Contributing factors: 
• Frequent and comprehensive screenings 
leading to high discovery rate
• Higher levels of vagal tone associated with 
higher levels of aerobic exercise
• Possible risk factors during 
spaceflight:
• Atrial distension due to fluid shift
• Increase in sympathetic activation
Integrated Cardiovascular Study
Co-PIs: Benjamin Levine, MD; Michael Bungo, MD
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• No potentially lethal arrhythmias were noted. 
• In one subject, there was a late-flight increase in supraventricular ectopy which did not 
persist post-flight (Khine et al, 2018)
• In a second subject there was increase in ventricular ectopy which occurred early in flight  
and persisted through the post-flight period (not shown)
NASA Astronaut Corps: Age by Status
Data as of 1/21/2020
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Purpose and Methods
Purpose
Review of atrial fibrillation / flutter outcomes among NASA astronauts in 
order to provide context for the risk of atrial arrhythmias during a deep 
space mission.  
Methods
Astronaut medical data available in NASA systems as of June 2019 were 
queried for ICD codes and keywords related to:  
• Atrial fibrillation or flutter (excluding postoperative)
• Ablation or cardioversion procedures
Compared prevalence of atrial fibrillation or flutter outcomes to European 
study
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Atrial Fibrillation / Flutter Diagnosis 
Among NASA Astronauts
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9 Ablations
13 Cardio-
version
Count of Type
Fibrillation 24
Paroxysmal 10
Flutter 7
Chronic 6
Postoperative 1
Grand Total 48
Age at Diagnosis
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Prevalence of Atrial Fibrillation 
by Age at Diagnosis (n=36)
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Atrial Fibrillation / Flutter Diagnosis 
Among NASA Astronauts
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9 crewmembers (25% of cases) were diagnosed during their active
career
• 3 did not fly a mission following their diagnosis
• 6 flew a mission after the diagnosis 
• 5 diagnosed before any flight
• 1 diagnosed between missions
• Of the 6 that flew: 
• 3 had an ablation 
• 1 had a cardioversion procedure
3 of 36 crewmembers were diagnosed within 3 years following a 
mission 
Total Days in Orbit prior to Diagnosis
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Recurrences
11 of 36 astronauts had an atrial fibrillation recurrence documented
• 1 was active at time of original and recurrent diagnosis (did not fly)
• 10 were retired at time of original and recurrent diagnoses
• One with a 3rd diagnosis
2 of 11 who had a recurrence also had a 2nd procedure 
• Both incident case and recurrence occurred following retirement
• One ablation case had a repeat approx. 3 years following first
• One cardioversion case had a repeat approx. 5 years following first
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Summary
Atrial fibrillation/flutter is observed in NASA astronauts with an increasing 
prevalence with aging
• Comparison to available data suggests no greater prevalence than in 
general population
• Working to compare astronauts to other healthy cohorts and examine 
contributions of other risk factors
Atrial fibrillation / flutter has not been diagnosed among NASA astronauts 
while in space
• Currently there is no evidence that the length or number of spaceflight 
exposures increases the risk of atrial fibrillation/flutter
• More evidence is needed to understand the complex interplay of aging and 
spaceflight especially with respect to proposed three year exploration 
missions
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